Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Japan Animal Referral Medical Center Co., Ltd. (6039)
Market Closed
12 Aug, 06:00
JPX
All
(1)
JP
(1)
JPX
Primary
¥
1,079.
00
+30
+2.8599%
¥
15.25B
Market Cap
-
P/E Ratio
32%
Div Yield
64,600
Volume
-
Eps
¥
1,049
Previous Close
Watching
Watch
Add Transaction
Day Range
1,063
1,089
Year Range
536.8
1,605
Want to track
6039
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Japan Animal Referral Medical Center Co., Ltd. (6039) Statistics
Valuation metrics
Market Cap
15.25B
Enterprise value
16.62B
Trailing P/E (ttm)
15.66
Forward P/E
6.79
PEG ratio
0.26
Price/Sales (ttm)
2.11
Price/Book (mrq)
2.67
Enterprise Value/Revenue
2.68
Enterprise Value/EBITDA
9.56
Overview
Shares outstanding
12.92M
Float
8M
Shares short
-
% Held by insiders
0.28%
% Held by institutions
0.34%
Average volume (10 days)
41.83K
Average volume (90 days)
104.79K
Price summary
52-Week low
536.8
52-Week high
1,605
Beta
0.59
50-Day moving average
1,027.23
200-Day moving average
1,196.02
Dividends and splits
Forward annual dividend rate
32
Forward annual dividend yield
0.0203%
Trailing annual dividend rate
12
Trailing annual dividend yield
0.0119%
5-Year annual dividend yield
-
Payout ratio
0.14
Dividend Date
-
Ex-Dividend Date
-
Last split factor
5:1
Last split Date
15 Dec 2025
Financials
Fiscal year
Fiscal year ends
31 Mar 2025
Most recent quarter (mrq)
31 Mar 2024
Profitability
Profit margin
0.13%
Operating margin
0.19%
Operational effectiveness
Return on assets
0.07%
Return on equity
0.18%
Income Statement
Revenue (ttm)
6B
Revenue per share (ttm)
479.11
Quarterly revenue growth (yoy)
0.18%
Gross profit (ttm)
2.33B
EBITDA
523.95M
Net income to common (ttm)
787.05M
Diluted EPS (ttm)
64.48
Quarterly earnings growth (yoy)
0.57%
Balance Sheet
Total cash (mrq)
1.22B
Total cash per share (mrq)
123.24
Total debt (mrq)
3.35B
Total Debt/Equity (mrq)
1.06
Current ratio (mrq)
0.56%
Book value per share (mrq)
377.67
Cash Flow
Cash flow statement
778.33M
Levered free cash flow (LFCF)
520.98M